Activity ID
13309Expires
June 18, 2027Format Type
EnduringCME Credit
1Fee
150CME Provider: Louisiana Medical Mutual Insurance Company (LAMMICO)
Description of CME Course
When a pregnant patient misuses or becomes dependent on any addictive substance during pregnancy, two people are exposed: the pregnant patient, and the fetus/newborn.
It is estimated that approximately 5% to 7% of pregnant persons use addictive substances. Among these, approximately 21% report misuse, 27% identify the need or desire to decrease or stop their use, and approximately 32% do not receive provider counseling of how their substance use could affect their infant. This activity will present a case study of SUD in pregnancy, highlighting the recognizable EFM changes along with strategies to address the effects.
ABMS Member Board Approvals by Type
ABMS Lifelong Learning CME Activity
Family Medicine
Commercial Support?
NoNOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
Educational Objectives
a. Analyze and critique a maternal and fetal case study to identify the symptoms of SUD or OUD and the fetal effects on a EFM strip.
b. Utilize evidence based interventions when caring for a pregnant patient with SUD or OUD with FHR or uterine activity abnormalities
c. Implement risk mitigation strategies when caring for this population of patients.
Keywords
Substance abuse, substance use disorder, SUD, opioid use
Competencies
Interpersonal & Communication Skills, Medical Knowledge, Patient Care & Procedural Skills, Practice-based Learning & Improvement, Professionalism
CME Credit Type
AMA PRA Category 1 Credit
Practice Setting
Inpatient, Rural, Urban, VA/Military
